Drugplain

Paxlovid

nirmatrelvir and ritonavir · KIT · Pfizer Laboratories Div Pfizer Inc

No Recall History
Plain English

Paxlovid is a kit containing nirmatrelvir and ritonavir. Manufactured by Pfizer Laboratories Div Pfizer Inc.

Key Facts

Brand Name
Paxlovid
Generic Name
nirmatrelvir and ritonavir
NDC Code (Product)
0069-5434
Manufacturer
Pfizer Laboratories Div Pfizer Inc
Dosage Form
KIT
Marketing Status
Application #
NDA217188
Marketing Start
07/09/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

covid-1922,798 reports
disease recurrence20,098 reports
dysgeusia7,339 reports
diarrhoea4,022 reports
nausea2,631 reports
headache2,170 reports
cough2,044 reports
fatigue2,011 reports
incorrect dose administered1,700 reports
vomiting1,401 reports

Frequently Asked Questions

What is Paxlovid used for?

Paxlovid contains nirmatrelvir and ritonavir. It is a kit taken as directed. Consult your doctor for specific uses.

Is Paxlovid a controlled substance?

Paxlovid is not classified as a controlled substance by the DEA.

What is the generic name for Paxlovid?

The generic name for Paxlovid is nirmatrelvir and ritonavir. There are no other listed brand versions of nirmatrelvir and ritonavir.

What is the NDC code for Paxlovid ?

The NDC (National Drug Code) for Paxlovid is 0069-5434, listed by Pfizer Laboratories Div Pfizer Inc.

Product NDC

0069-5434

Package NDC

0069-5434-20

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)